Joel Thompson is a biotech executive with deep ophthalmology experience and a track record of shaping strategy across clinical, commercial, and investor-facing areas. He is VP of Strategy at Tavo Biotherapeutics, advancing neuroinflammation therapies targeting the root causes of vision-threatening diseases. Thompson’s career spans ophthalmology and consumer goods, with a decade of experience founding and advising eye care companies. He brings an integrated view of the landscape, supported by strong relationships with top clinicians, KOLs, and industry leaders. Previously, Thompson was in management consulting at McKinsey & Company, advising clients from Fortune 50 firms to PE-backed startups on product launches, growth initiatives, and corporate strategy. He holds a BA from Augustana University and an MBA from NYU Stern School of Business